Provided by Tiger Fintech (Singapore) Pte. Ltd.

XBiotech

3.42
-0.1000-2.84%
Volume:46.74K
Turnover:162.16K
Market Cap:104.25M
PE:-3.18
High:3.61
Open:3.48
Low:3.42
Close:3.52
Loading ...

Company Profile

Company Name:
XBiotech
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
92
Office Location:
5217 Winnebago Lane,Austin,Texas,United States
Zip Code:
78744
Fax:
- -
Introduction:
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Directors

Name
Position
John Simard
Founder, President, Chief Executive Officer & Chairman
Daniel Vasella
Director
Fabrizio Bonanni
Director
W. Thorpe McKenzie
Director

Shareholders

Name
Position
John Simard
Founder, President, Chief Executive Officer & Chairman
Kelly Thornburg
Senior Vice President of Operations
Joseph Benson
Vice President of Commercial Development
Michael Stecher
Medical Director
Queena Han
Vice President, Finance and Human Resources and Secretary
Sushma Shivaswamy
Vice President of Research and Development